Cladribine prolongs progression-free survival and time to second treatment compared to fludarabine and high-dose chlorambucil in chronic lymphocytic leukemia.

Autor: Mulligan, Stephen P.1 (AUTHOR) mulligan@sydney.edu.au, Karlsson, Karin2,3 (AUTHOR), Strömberg, Mats4 (AUTHOR), Jønsson, Viggo5 (AUTHOR), Gill, Devinder6 (AUTHOR), Hammerström, Jens7 (AUTHOR), Hertzberg, Mark8 (AUTHOR), McLennan, Roger9 (AUTHOR), Uggla, Bertil10 (AUTHOR), Norman, John11 (AUTHOR), Wallvik, Jonas12 (AUTHOR), Sundström, Gunnel13 (AUTHOR), Johansson, Hemming14 (AUTHOR), Brandberg, Yvonne14 (AUTHOR), Liliemark, Jan4,15 (AUTHOR), Juliusson, Gunnar2,3 (AUTHOR)
Zdroj: Leukemia & Lymphoma. Dec2014, Vol. 55 Issue 12, p2769-2777. 9p.
Databáze: Academic Search Ultimate
Externí odkaz:
Nepřihlášeným uživatelům se plný text nezobrazuje